MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Direxion Daily Pharmaceutical & Medical Bull 3X ETF (NY:PILL)

20.75 +2.11 (+11.32%)
Official Closing Price Updated: 8:00 PM EDT, Jul 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 209,807
Open 19.82
Bid (Size) 20.51 (200)
Ask (Size) 21.50 (200)
Prev. Close 18.64
Today's Range 19.80 - 21.00
52wk Range 5.200 - 21.00
Shares Outstanding N/A
Dividend Yield 0.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them." 
Via Benzinga
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers. 
Via Benzinga
Topics Government World Trade

Performance

YTD
+76.4%
+76.4%
1 Month
+79.3%
+79.3%
3 Month
+96.7%
+96.7%
6 Month
+76.6%
+76.6%
1 Year
+291.5%
+291.5%

More News

Read More
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
Via Benzinga
3 Pharmaceutical ETFs That Could Be Due For A Rebound ↗
Via Benzinga
News headline image
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗
Via Benzinga
News headline image
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗
Via Benzinga
Topics Government World Trade
News headline image
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗
Via Benzinga
News headline image
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion ↗
Via Benzinga
Topics Government
News headline image
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗
Via Benzinga
Topics Government World Trade
News headline image
3 Pharmaceutical ETFs That Could Be Due For A Rebound ↗
Via Talk Markets

Frequently Asked Questions

Is Direxion Daily Pharmaceutical & Medical Bull 3X ETF publicly traded?
Yes, Direxion Daily Pharmaceutical & Medical Bull 3X ETF is publicly traded.
What exchange does Direxion Daily Pharmaceutical & Medical Bull 3X ETF trade on?
Direxion Daily Pharmaceutical & Medical Bull 3X ETF trades on the New York Stock Exchange
What is the ticker symbol for Direxion Daily Pharmaceutical & Medical Bull 3X ETF?
The ticker symbol for Direxion Daily Pharmaceutical & Medical Bull 3X ETF is PILL on the New York Stock Exchange
What is the current price of Direxion Daily Pharmaceutical & Medical Bull 3X ETF?
The current price of Direxion Daily Pharmaceutical & Medical Bull 3X ETF is 20.75
When was Direxion Daily Pharmaceutical & Medical Bull 3X ETF last traded?
The last trade of Direxion Daily Pharmaceutical & Medical Bull 3X ETF was at 07/07/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story